Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
In the realm of medical technology, a noticeable divide exists between developed and developing countries, with the former enjoying the benefits of advanced devices, while the latter often relies on traditional methods and large-scale equipment. This technological gap is particularly evident in the field of bilirubin blood testing. Developed nations such as the U.S., Japan, and Germany boast access to cutting-edge portable bilirubin blood test devices, facilitating more efficient and streamlined diagnostic processes. In contrast, many developing countries, grappling with slower technological advancements and limited access to such sophisticated devices, continue to employ traditional methods and bulky equipment.
This disparity in technological adoption presents a unique market dynamic, with untapped opportunities for growth in developing regions. Countries like China and India, marked by burgeoning populations and a growing need for advanced healthcare solutions, emerge as potential markets for the expansion of the bilirubin blood test market. However, challenges persist, as major manufacturers predominantly based in developed nations tend to distribute their devices globally, including to developing countries. This approach can inadvertently escalate the cost of these advanced products, limiting accessibility for healthcare professionals in regions with constrained resources.
To address this issue and seize untapped opportunities, manufacturers are encouraged to reevaluate their distribution strategies. Instead of primarily focusing on established markets in developed nations, they can redirect their attention to the unexplored potential in developing countries. By doing so, manufacturers not only contribute to bridging the technological gap but also position themselves to capture a significant share of emerging markets.
The evolving landscape of global healthcare demands a more inclusive approach, recognizing the diverse needs and resources of both developed and developing regions. Manufacturers should consider adapting their products to cater to the specific requirements of developing countries, keeping in mind factors such as cost-effectiveness, ease of use, and compatibility with existing healthcare infrastructure.
In addition to expanding market reach, this shift in focus can have positive implications for public health in developing nations. Access to advanced diagnostic tools, such as portable bilirubin blood test devices, can enhance the efficiency and accuracy of medical assessments. This, in turn, contributes to early detection and intervention for conditions like neonatal jaundice, significantly improving health outcomes.
Collaborative efforts between manufacturers, healthcare professionals, and regulatory bodies can further facilitate the introduction of advanced medical technologies in developing regions. Initiatives aimed at reducing barriers to entry, providing training programs for healthcare personnel, and optimizing supply chains can accelerate the integration of innovative healthcare solutions.
The global landscape of medical technology is marked by a stark contrast between developed and developing countries. The potential for growth in the bilirubin blood test market lies in addressing this divide by redirecting focus toward untapped opportunities in regions with evolving healthcare needs. Manufacturers have a pivotal role in driving this transformation, not only by expanding market reach but also by contributing to the improvement of healthcare standards in developing nations.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Test Type, Product Type, Applications and End User |
Bilirubin Blood Test Market Highlights:
Bilirubin Blood Test Market Analysis:
A yellowish-orange substance present in the human blood is called bilirubin. This natural coloring is secreted by our liver. It is discharged in bile and is formed from the breaking down of hemoglobin. From the blood, it reaches the liver and gets stored there. Bilirubin gets removed from the body through excretory passages. The condition of high bilirubin level is common in infants. It results in the yellowing of skin and eyes. A bilirubin blood test is conducted to check the level of yellow bilirubin in the blood. When the liver is functioning properly, it expels all the bilirubin from the body. In case the level of bilirubin is high, it gets drained from the liver and causes diseases such as jaundice, dark urine, and others. A high bilirubin blood test enables us to monitor the count of bilirubin in the blood, therefore, detects the problems related to gallbladders.
Bilirubin Blood Test Market size is calculated to index a 6.30% CAGR. It is estimated that its market value will shoot up to USD 2.32 Billion during the forecast (2022-2030).
Covid19 Analysis
Due to the spread of infectious coronavirus, people are facing several respiratory problems. Many patients have reported high blood test bilirubin levels, which is a serious concern. Although the death rate because of rising in bilirubin level is not high.
The government and medical agencies are investing in Research & Development programs. It will make rapid diagnosis easy. Low bilirubin blood test and high bilirubin blood test include a cumbersome process of sample collection, fluid handling, device packaging, etc. Therefore, a need arises to develop more effective ways of conducting the bilirubin blood test with the least spoilage.
Market Dynamics
Drivers
The diseases such as jaundice, dark urine, and problems related to the gallbladder, are increasing rapidly. It is leading to the rise in demand for bilirubin blood testing apparatus. New-born children or infants are more prone to such problems because their liver is not absorbing bilirubin properly immediately after their birth. This has boosted the market demand for portable and easy-to-use testing kits. Thus, the bilirubin blood test market size is expected to grow rapidly throughout the forecasted period.
Opportunities
Bilirubin blood test market growth can be attributed to the constant technological changes. The need for developing new apparatus and techniques of testing is increasing so that more accurate and trustworthy results can be drawn. The transferable and easy-to-use testing kits are being developed for this purpose. People are becoming aware and are adapting to a healthy lifestyle. The government of every nation is also investing its resources in healthcare camps where a large number of people are treated. This has amplified the bilirubin blood testing percentage.
Restraints
Some other sorts of testing techniques that are being used by people or agencies other than the pathological labs or research institutes are proposing a real threat to bilirubin blood testing market size. The test conducted by non-pathological personnel is not trustworthy and can show false results.
Value Chain Analysis
The key players in the field of the bilirubin blood test market are making technological advancements. They are launching such instruments which will require a minimum ounce of blood for testing the level of bilirubin in the blood of a patient. As the cases of jaundice are more in infants and newborns, the companies are developing techniques that will be less painful and will cause no harm to them.
Market Segmentation
Bilirubin blood test market can be divided into various segments. These are: based on test type, based on product type, based on application, and based on end-users.
Based on test type
Various kinds of tests conducted in bilirubin blood test market are as follows: Total Serum Bilirubin (TSB); Direct/Conjugated Bilirubin Test; Indirect/Unconjugated Bilirubin Test
Based on product type
Based on product type, the bilirubin blood test market is divided into two types, namely, consumables and instruments. Consumables are not reusable materials. Consumables alone accounted for a market stake of 47.37% in the year 2015, which was the highest among all other segments. The instruments can further be classified into analyzers and bilirubin meters.
Based on application
The market is divided into infants or newborn children and adults. The chances of jaundice in pediatrics are more than that of adults, therefore, infants form the largest percentage of the consumers of the bilirubin blood test market.
Based on end-users
Bilirubin blood testing is done at diagnostics centers, pathological labs, and hospitals. Research laboratories and other academic institutions also contribute a large share to the market. Pediatric clinics and child specialist hospitals are also end-user.
Regional Analysis
Bilirubin blood test market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include North America, Europe, Asia-pacific, and the rest of the world.
North America, which includes the area of the US and Canada, is overshadowing all the other regions. It accounted for a share of 39.10% in the year 2014, which was the largest in the global bilirubin blood test market. The market share of the US alone is anticipated to reach a CAGR of 4.93%.
The European region, which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the bilirubin blood test market. It is presumed that Germany will touch the largest value, accounting for USD 158.6 million, by the end of the year 2027.
Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for bilirubin blood testing. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. The market of these regions will grow with a CAGR of 6.45%. China alone had a market share of 34.10% in the year 2015.
The rest of the world, which includes regions of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.
Competitive Landscape
The list of major key players involved in the global bilirubin blood test market analysis is as follows:
- Koninklijke Philips N.V. (Noord-Holland)
- Beckman Coulter, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Randox Laboratories Ltd. (UK)
- Hoffmann-La Roche AG (Switzerland)
- Drägerwerk AG & Co. KGaA (Germany)
- Ginevri (Italy)
- Advanced Instruments (US)
- Reichert, Inc. (US)
- Instrumentation Laboratory (US).
- AVI Healthcare Pvt. Ltd.
The above-listed companies work on the testing and origination of new equipment and techniques in the field of bilirubin blood testing. They come together in joint ventures, mergers, and, acquisitions, launching new devices. Their main objective is to deliver devices that are cost-effective, hassle-free in operations, and give concrete results.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
